By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced the expansion of a global sales and distribution deal with Bio-Rad Laboratories to 2023 as well as the granting of the global sales and distribution rights for the Magpix multiplexing platform.

Under the terms of the agreement Bio-Rad will offer Luminex's xMAP systems, including the Magpix system, which detects up to 50 different analytes on a single sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.